About the Study

Growth Hormone Deficiency: A study in prepubertal children to help treat GHD

This study is being done for children: • At the Screening Visit, be age ≥ 3.0 years and age ≤ 10.0 years for girls and ≤ 11.0 years for boys. • Growth Hormone Deficiency • Must be Naïve to treatment Lumos Pharma, LLC. (the Sponsor) is conducting a research study to see if a study drug not yet approved for market, named LUM-201, will help in the treatment of pediatric Growth Hormone Deficiency (GHD) and how safe it is to use in children.

Interested in learning more?

Full Study Name: LUM-201-10